(Q36608502)

15 August 2017

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival (English)

1 reference

15 August 2017

1 reference

1 reference

Jd Wright

1

1 reference

15 August 2017

T Doan

2

1 reference

15 August 2017

R McBride

3

1 reference

15 August 2017

Js Jacobson

4

1 reference

15 August 2017

Dl Hershman

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

18 March 2008

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

98

1 reference

15 August 2017

7

1 reference

15 August 2017

1197-1203

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604298

15 August 2017

0 references

cites work

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Utility of the SEER-Medicare data to identify chemotherapy use.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Assessing comorbidity using claims data: an overview

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Development of a comorbidity index using physician claims data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Racial differences in the treatment of early-stage lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Ovarian cancer surgery in Maryland: volume-based access to care.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359630

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

20 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Variations in the Use of Chemotherapy for Elderly Patients With Advanced Ovarian Cancer: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604298

Timing of chemotherapy and surgery in a murine osteosarcoma model

21 January 2018

1 reference

12 December 2020

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

1 reference

12 December 2020

How many more nails to seal the coffin of dose intensity?

1 reference

12 December 2020

Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group

1 reference

12 December 2020

Racial disparities in treatment and survival among women with early-stage breast cancer

1 reference

12 December 2020

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection

1 reference

12 December 2020

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

1 reference

12 December 2020

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women

1 reference

12 December 2020

Ovarian cancer: patterns of surgical care across the United States

1 reference

12 December 2020

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

1 reference

12 December 2020

Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?

1 reference

12 December 2020

Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome

1 reference

12 December 2020

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens

1 reference

12 December 2020

The effect of centralization of primary surgery on survival in ovarian cancer patients

1 reference

12 December 2020

Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group

1 reference

12 December 2020

A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?

1 reference

12 December 2020

Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer

1 reference

12 December 2020

Outcomes in surgery for ovarian cancer

1 reference

12 December 2020

Does Timing of Adjuvant Chemotherapy for Early Breast Cancer Influence Survival?

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604298

1 reference

15 August 2017

1 reference

15 August 2017

1 reference